HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sonazoid

contrast media containing monodisperse magnetic particles; the particles consist of small crystals of iron oxide, gamma-ferric oxide (gamma-Fe2O) & magnetite (Fe3O4), coating a polymer carrier matrix
Also Known As:
DD-723; NC100100
Networked: 216 relevant articles (28 outcomes, 55 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sumino, Yasukiyo: 22 articles (07/2019 - 04/2010)
2. Kudo, Masatoshi: 19 articles (01/2021 - 01/2008)
3. Shiozawa, Kazue: 14 articles (03/2017 - 04/2010)
4. Watanabe, Manabu: 14 articles (03/2017 - 04/2010)
5. Kamiyama, Naohisa: 12 articles (08/2022 - 04/2010)
6. Igarashi, Yoshinori: 12 articles (01/2019 - 09/2011)
7. Wakui, Noritaka: 12 articles (01/2019 - 04/2010)
8. Numata, Kazushi: 10 articles (06/2021 - 03/2008)
9. Ikehara, Takashi: 10 articles (03/2017 - 06/2013)
10. Sugimoto, Katsutoshi: 9 articles (08/2022 - 04/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Hepatocellular Carcinoma (Hepatoma)
3. Neoplasm Metastasis (Metastasis)
4. Breast Neoplasms (Breast Cancer)
5. Focal Nodular Hyperplasia

Related Drugs and Biologics

1. perfluorobutane (AI 700)
2. contrast agent BR1
3. Gadolinium
4. Contrast Media
5. Pentetic Acid (DTPA)
6. diethylenetriamine
7. Sulfur Hexafluoride
8. gadolinium ethoxybenzyl DTPA
9. B7-H1 Antigen
10. Acids

Related Therapies and Procedures

1. Therapeutics
2. Microbubbles
3. Radiofrequency Ablation
4. Radiotherapy
5. Drug Therapy (Chemotherapy)